Review decisions
Showing 270 results of 2627 total
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732546621694
Product Type: Drug
Control Number: 279169
DIN(s): 02417162, 02417170, 02469510
Manufacturer: AbbVie corp.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-09-18
Decision / Authorization Date: 2024-05-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732553051076
Product Type: Drug
Control Number: 271199
DIN(s): 02550423
Manufacturer: Bausch Heath Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-06-06
Decision / Authorization Date: 2024-08-14
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732551487982
Product Type: Drug
Control Number: 273065
Manufacturer: Bausch Health Canada Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2023-03-03
Decision / Authorization Date: 2024-08-16
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1741877886786
Product Type: Drug
Control Number: 278103
DIN(s): 02480522
Manufacturer: ENDO Operations Ltd.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-08-04
Decision / Authorization Date: 2024-07-24
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1741697600616
Product Type: Drug
Control Number: 265823
DIN(s): 02548283
Manufacturer: Seaford Pharmaceuticals Inc.
Submission Type: New Drug Submission
Date Filed / Submission Date: 2022-07-12
Decision / Authorization Date: 2024-05-30
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1729085441755
Product Type: Drug
Control Number: 281318
DIN(s): 02468816
Manufacturer: AstraZeneca Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-11-20
Decision / Authorization Date: 2024-10-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1729098917291
Product Type: Drug
Control Number: 281745
DIN(s): 02551012, 02551020, 02551039
Manufacturer: Novo Nordisk Canada Inc.
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-12-01
Decision / Authorization Date: 2024-10-08
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1732302431707
Product Type: Drug
Control Number: 280033
Manufacturer: ViiV Healthcare ULC
Submission Type: NDS for Priority Review
Date Filed / Submission Date: 2023-10-17
Decision / Authorization Date: 2024-05-10
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/RDS1728568404321
Product Type: Drug
Control Number: 279827
DIN(s): 02527138
Manufacturer: Bristol-Myers Squibb Canada
Submission Type: Supplement to a New Drug Submission
Date Filed / Submission Date: 2023-10-11
Decision / Authorization Date: 2024-09-25
https://dhpp.hpfb-dgpsa.ca/review-documents/resource/SBD1775850909553
Product Type: Drug
Control Number: 290788
DIN(s): 02564653, 02564661, 02564688
Manufacturer: BioMarin International Limited
Submission Type: New Drug Submission (New Active Substance)
Date Filed / Submission Date: 2024-10-01
Issued / Original Publication Date: 2026-04-09
Decision / Authorization Date: 2026-01-21